Efeito do índice de massa corporal na resposta ao tratamento com DMARDs biológicos/sintéticos direcionados em pacientes com artrite reumatoide, artrite psoriática ou espondiloartrite axial. Uma revisão sistemática
Autoimmunity Reviews 22 (2023) 103357
The study demonstrated that obesity is a factor that could play a role in treatment decision-making in people living with inflammatory arthritis (IA). It appears that efficacy of TNFi is affected by patients’ weight/BMI in all forms of IA, while this is not the case for TCZ and ABA in RA, as well for IL-17 and IL-23 inhibitors in PsA.